| Huntington disease: natural history, biomarkers and prospects for therapeutics CA Ross, EH Aylward, EJ Wild, DR Langbehn, JD Long, JH Warner, ... Nature Reviews Neurology 10 (4), 204-216, 2014 | 1088 | 2014 |
| Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ... The Lancet Neurology 8 (9), 791-801, 2009 | 1073 | 2009 |
| Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, ... The Lancet Neurology 12 (7), 637-649, 2013 | 964 | 2013 |
| Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ... The Lancet Neurology 10 (1), 31-42, 2011 | 667 | 2011 |
| Technology in Parkinson's disease: challenges and opportunities AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ... Movement Disorders 31 (9), 1272-1282, 2016 | 651 | 2016 |
| Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data SJ Tabrizi, R Reilmann, RAC Roos, A Durr, B Leavitt, G Owen, R Jones, ... The Lancet Neurology 11 (1), 42-53, 2012 | 601 | 2012 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 445 | 2012 |
| Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 322 | 2017 |
| Diagnostic criteria for Huntington's disease based on natural history R Reilmann, BR Leavitt, CA Ross Movement Disorders 29 (11), 1335-1341, 2014 | 261 | 2014 |
| A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies AJ Espay, JM Hausdorff, Á Sánchez‐Ferro, J Klucken, A Merola, P Bonato, ... Movement Disorders 34 (5), 657-663, 2019 | 253 | 2019 |
| Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial JG de Yebenes, B Landwehrmeyer, F Squitieri, R Reilmann, A Rosser, ... The Lancet Neurology 10 (12), 1049-1057, 2011 | 201 | 2011 |
| International guidelines for the treatment of Huntington's disease AC Bachoud-Lévi, J Ferreira, R Massart, K Youssov, A Rosser, M Busse, ... Frontiers in neurology 10, 710, 2019 | 183 | 2019 |
| TRACK-HD investigators. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data SJ Tabrizi, DR Langbehn, BR Leavitt, RA Roos, A Durr, D Craufurd, ... Lancet Neurol 8 (9), 791-801, 2009 | 177 | 2009 |
| Tapping linked to function and structure in premanifest and symptomatic Huntington disease N Bechtel, RI Scahill, HD Rosas, T Acharya, SJA van den Bogaard, ... Neurology 75 (24), 2150-2160, 2010 | 174 | 2010 |
| Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease EM Dumas, SJA van den Bogaard, ME Ruber, R Reilmann, JC Stout, ... Human brain mapping 33 (1), 203-212, 2012 | 158 | 2012 |
| Creatine supplementation lowers brain glutamate levels in Huntington’s disease A Bender*, DP Auer*, T Merl, R Reilmann, P Saemann, A Yassouridis, ... Journal of neurology 252, 36-41, 2005 | 157 | 2005 |
| Compensation in preclinical Huntington's disease: evidence from the track-on HD study S Klöppel, S Gregory, E Scheller, L Minkova, A Razi, A Durr, RAC Roos, ... EBioMedicine 2 (10), 1420-1429, 2015 | 146 | 2015 |
| Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy RI Scahill, NZ Hobbs, MJ Say, N Bechtel, SMD Henley, H Hyare, ... Human brain mapping 34 (3), 519-529, 2013 | 144 | 2013 |
| Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease A Sturrock, C Laule, J Decolongon, R Dar Santos, AJ Coleman, ... Neurology 75 (19), 1702-1710, 2010 | 136 | 2010 |
| Coordination of prehensile forces during precision grip in Huntington's disease AM Gordon, L Quinn, R Reilmann, K Marder Experimental neurology 163 (1), 136-148, 2000 | 131 | 2000 |
